14. Schwitalle Y, Linnebacher M, Ripberger E, Gebert J, von Knebel Doeberitz M. Immunogenic peptides generated by frameshift mutations in DNA mismatch repair-de ﬁcient cancer cells. Cancer Immun 2004;4:14. 15. Maletzki C, Schmidt F, Dirks WG, Schmitt M, Linnebacher M. Frameshift- derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies: frameshift peptides for treating MSI þblood cancers. Eur J Cancer 2013;49:2587 –95.